Brief: Sesen Bio Reports First Quarter 2022 Financial Results

Carisma Therapeutics

09/05/2022 13:31

May 9 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
BUSINESS UPDATE
    * SESEN BIO INC- $170 MILLION IN CASH AND CASH EQUIVALENTS
AS OF
MARCH 31, 2022, EXPECTED TO FUND CURRENT OPERATING PLAN INTO Q4
OF 2024
    * SESEN BIO INC - QTRLY LOSS PER SHARE $0.00

Source text for Eikon:  ID:nBw6lFdRya 
Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))